Suspension of Avandia (rosiglitazone) from New Zealand market
The medicine for diabetes called rosiglitazone is to be withdrawn from the NZ market from April 2011 following saftey review that has found increased risk of cardiovascular issues.
Online Press Release Service for New Zealand